IFP Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
RWS
EP
IFP Advisors's IRMD Position: Q3 2026 in Review
IFP Advisors increased its iRadimed (IRMD) stake by 308% in Q3 2026, buying an estimated $158K and bringing the position to 2,324 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.
IFP Advisors first reported a position in IRMD in Q2 2017 and has held it in 10 quarters since. 18 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- IFP Advisors held 2,324 shares of iRadimed worth $200K as of Q3 2026.
- IFP Advisors bought 1,755 iRadimed shares in Q3 2026, an estimated $158K.
- iRadimed made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #1531 holding.
- IFP Advisors first reported a position in iRadimed in Q2 2017 and has held it in 10 quarters since.
- 18 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.